THE EFFECTIVENESS OF EARLY ANTIVIRAL THERAPY IN COVID-19 SEVERITY

Аннотация

The global outbreak of COVID-19 has led to a critical need for effective therapeutic strategies. Among these, early administration of antiviral agents such as remdesivir and molnupiravir has shown potential to reduce disease severity and improve clinical outcomes. This study investigates the clinical impact of initiating antiviral therapy during the early phase of SARS-CoV-2 infection, focusing onhospitalization rates, ICU admissions,and mortality. Keywords: COVID-19, SARS-CoV-2, antiviral therapy, remdesivir, early treatment, clinical outcomes